Recombinant DNA/microbial pathogens?

Answer this question ‘Yes’ if the proposal involves any of the terms below or involves any biohazardous and/or recombinant materials. For assistance, contact Research Laboratory & Safety Services at (520) 626-6850 or sends e-mail) or visit the Recombinant and Biohazardous Materials web page.

If the project you are proposing involves the handling or storage of Risk Group 3 biohazardous and/or recombinant materials that would require the use of a BSL-3 laboratory, please contact Research Laboratory & Safety Services at BSL-3 work must be approved in advance by the Institutional Biosafety Committee (IBC). You can access the documents needed to submit to the committee at  Institutional Biosafety Committee | UArizona Research, Innovation & Impact. Access and training for the BSL-3 spaces is a lengthy process, so reaching out to RLSS early in the process is optimal.

  • Adenovirus
  • Adenoassociated Virus
  • AAV
  • Cloning
  • Gene therapy
  • Genomic library
  • Microarray
  • Plasmid
  • Probes
  • Recombinant
  • Retrovirus
  • Restriction fragment polymorphism (RFLP)
  • Sequencing
  • Southern / Northern hybridization
  • Transformed cells
  • Vector
  • Bordetella pertussis
  • Campylobacter
  • Cell Culture
  • Coccidiodes
  • Chlamydia
  • Clostridium
  • Coxiella
  • Cryptosporidium
  • Cyclospora
  • Giardia
  • herpes
  • HIV
  • Influenza
  • Monkeypox
  • Mycobacterium
  • Yesinia pestis (plague)
  • Salmonella
  • Toxin
  • Vaccinia
  • SARS-CoV-2
  • Risk Group 2
  • Risk Group 3
  • Virus
  • Bacteria
  • Fungus
  • Parasite
  • Rickettsia

FAQ Page


Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.

Subscribe now